Chronic hepatitis C: Interferon may be harmful in re-treatment: “may face an increased risk of dying sooner”

Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated…

Cochrane Review finds no benefit from routine health checks

Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley Carrying out general health checks does not reduce deaths overall or from serious diseases like cancer and heart disease, according to Cochrane researchers. The researchers, who carried out a systematic review on the subject for The Cochrane Library, warn against offering general health checks as part of a public…